The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Oligomycin-induced Bioenergetic Adaptation in Cancer Cells with Heterogeneous Bioenergetic Organization
Open accessAbstract
Cancer cells constantly adapt to oxidative phosphorylation (OXPHOS) suppression resulting from hypoxia or mitochondria defects. Under the OXPHOS suppression, AMP-activated protein kinase (AMPK) regulates global metabolism adjustments, but its activation has been found to be transient. Whether cells can maintain cellular ATP homeostasis and survive beyond the transient AMPK activation is not known. Here, we study the bioenergetic adaptation to the OXPHOS inhibitor oligomycin in a group of cancer cells. We found that oligomycin at 100 ng/ml completely inhibits OXPHOS activity in 1 h and induces various levels of glycolysis gains by 6 h, from which we calculate the bioenergetic organizations of cancer cells. In glycolysis-dominant cells, oligomycin does not induce much energy stress as measured by glycolysis acceleration, ATP imbalance, AMPK activation, AMPK substrate acetyl-CoA carboxylase phosphorylation at Ser(79), and cell growth inhibition. In OXPHOS-dependent LKB1 wild type cells, oligomycin induces 5-8% ATP drops and transient AMPK activation during the initial 1-2 h. After AMPK activation is completed, oligomycin-induced increase of acetyl-CoA carboxylase phosphorylation at Ser(79) is still detected, and cellular ATP is back at preoligomycin treatment levels by sustained elevation of glycolysis. Cell growth, however, is inhibited without an increase in cell death and alteration in cell cycle distribution. In OXPHOS-dependent LKB1-null cells, no AMPK activation by oligomycin is detected, yet cells still show a similar adaptation. We also demonstrate that the adaptation to oligomycin does not invoke activation of hypoxia-induced factor. Our data suggest that cancer cells may grow and survive persistent OXPHOS suppression through an as yet unidentified regulatory mechanism.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the use of this oligomycin concentration is common in the literature and causes a minor nonspecific effect on mitochondrial and cellular function [15,25,26,27].”
From Proliferating Astrocytes in Primary Culture Do Not Depend upon Mitochondrial Respiratory Complex I Activity or Oxidative Phosphorylation (2023) · cites this paper as [15]
In the citing paper
“Notably, cultured cancer cells were able to grow and survive even under the inhibition of oxidative phosphorylation by oligomycin [15].”
From Proliferating Astrocytes in Primary Culture Do Not Depend upon Mitochondrial Respiratory Complex I Activity or Oxidative Phosphorylation (2023) · cites this paper as [15]
In the citing paper
“However, we used 10 times more oligomycin in our experiments since this oligomycin concentration elicits minor nonspecific effects and it is common in the literature [15,25,26,27].”
From Proliferating Astrocytes in Primary Culture Do Not Depend upon Mitochondrial Respiratory Complex I Activity or Oxidative Phosphorylation (2023) · cites this paper as [15]
In the citing paper
“These findings confirm previous studies that analyzed inhibition of either glycolysis or OXPHOS, and observed an increase in the activity of the other pathway (Hao et al., 2010; Jose et al., 2011; Birsoy et al., 2014; Dykens et al., 2008).”
From Combination of Hypoglycemia and Metformin Impairs Tumor Metabolic Plasticity and Growth by Modulating the PP2A-GSK3β-MCL-1 Axis (2019) · cites this paper as Hao et al., 2010
Citations
Cites
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652
Why Do Cancers Have High Aerobic Glycolysis?
Gatenby, R. A., & Gillies, R. J. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1478 · Cited by 4,784
The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G., & Thompson, C. B. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.002 · Cited by 4,088
Wallace, D. C. (2005) · Annual Review of Genetics · doi:10.1146/annurev.genet.39.110304.095751 · Cited by 3,185
Kahn, B. B., Alquier, T., Carling, D., & Hardie, D. G. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2004.12.003 · Cited by 2,799
Tumor cell metabolism: cancer's Achilles' heel
Kroemer, G., & Pouyssegur, J. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.05.005 · Cited by 2,337
p53 Regulates Mitochondrial Respiration
Matoba, S., Kang, J.-G., Patino, W. D., Wragg, A., Boehm, M., Gavrilova, O., Hurley, P. J., Bunz, F., & Hwang, P. M. (2006) · Science · doi:10.1126/science.1126863 · Cited by 1,650
ROS-Generating Mitochondrial DNA Mutations Can Regulate Tumor Cell Metastasis
Ishikawa, K., Takenaga, K., Akimoto, M., Koshikawa, N., Yamaguchi, A., Imanishi, H., Nakada, K., Honma, Y., & Hayashi, J.-I. (2008) · Science · doi:10.1126/science.1156906 · Cited by 1,444
Management of cellular energy by the AMP‐activated protein kinase system
Hardie, D. G., Scott, J. W., Pan, D. A., & Hudson, E. R. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00560-x · Cited by 868
Research works printed but not linked: 2
- Cuezva, 2002, Cancer Res., 62, 6674
- Russell, 1999, Am. J. Physiol., 277, H643
Cited by
Sorted by citations
An inhibitor of oxidative phosphorylation exploits cancer vulnerability
Molina, J. R., Sun, Y., Protopopova, M., Gera, S., Bandi, M., Bristow, C., McAfoos, T., Morlacchi, P., Ackroyd, J., Agip, A.-N. A., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0052-4 · Cited by 928
Roesch, A., Vultur, A., Bogeski, I., Wang, H., Zimmermann, K. M., Speicher, D., Körbel, C., Laschke, M. W., Gimotty, P. A., Philipp, S. E., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.05.003 · Cited by 670
Liu, Y., Cao, Y., Zhang, W., Bergmeier, S. C., Qian, Y., Akbar, H., Colvin, R. A., Ding, J., Tong, L., Wu, S., et al. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0131 · Cited by 586
Yang, L., Moss, T., Mangala, L. S., Marini, J., Zhao, H., Wahlig, S., Armaiz‐Pena, G., Jiang, D., Achreja, A., Win, J., et al. (2014) · Molecular Systems Biology · doi:10.1002/msb.20134892 · Cited by 326
Elgendy, M., Cirò, M., Hosseini, A., Weiszmann, J., Mazzarella, L., Ferrari, E., Cazzoli, R., Curigliano, G., DeCensi, A., Bonanni, B., et al. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.03.007 · Cited by 299
Davis, R. T., Blake, K., Ma, D., Gabra, M. B. I., Hernandez, G. A., Phung, A. T., Yang, Y., Maurer, D., Lefebvre, A. E. Y. T., Alshetaiwi, H. S., et al. (2020) · Nature Cell Biology · doi:10.1038/s41556-020-0477-0 · Cited by 301
Inflammasomes on the Crossroads of Innate Immune Recognition and Metabolic Control
Próchnicki, T., & Latz, E. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.06.018 · Cited by 302
Tumor-Associated Macrophages Enhance Tumor Hypoxia and Aerobic Glycolysis
Jeong, H., Kim, S., Hong, B.-J., Lee, C.-J., Kim, Y.-E., Bok, S., Oh, J.-M., Gwak, S.-H., Yoo, M. Y., Lee, M. S., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-2545 · Cited by 272
Oxidative phosphorylation in cancer cells
Solaini, G., Sgarbi, G., & Baracca, A. (2010) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2010.09.003 · Cited by 233
Grasso, D., Zampieri, L. X., Capelôa, T., de Velde, J. A. V., & Sonveaux, P. (2020) · Cell Stress · doi:10.15698/cst2020.06.221 · Cited by 239
Shen, Y.-C., Ou, D., Hsu, C., Lin, K.-L., Chang, C.-Y., Lin, C.-Y., Liu, S., & Cheng, A.-L. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.559 · Cited by 202
A tumour-selective cascade activatable self-detained system for drug delivery and cancer imaging
An, H.-W., Li, L., Wang, Y., Wang, Z., Hou, D., Lin, Y.-X., Qiao, S., Wang, M., Yang, C., Cong, Y., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12848-5 · Cited by 195
Adenine nucleotide translocase 2 is a key mitochondrial protein in cancer metabolism
Chevrollier, A., Loiseau, D., Reynier, P., & Stepien, G. (2010) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2010.10.008 · Cited by 188
C13orf31 (FAMIN) is a central regulator of immunometabolic function
Cader, M. Z., Boroviak, K., Zhang, Q., Assadi, G., Kempster, S. L., Sewell, G. W., Saveljeva, S., Ashcroft, J., Clare, S., Mukhopadhyay, S., et al. (2016) · Nature Immunology · doi:10.1038/ni.3532 · Cited by 173
Nishikawa, T., Bellancé, N., Damm, A., Bing, H., Zhu, Z. H., Handa, K., Yovchev, M. I., Sehgal, V., Moss, T. J., Oertel, M., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.02.014 · Cited by 139
Titanium dioxide nanoparticles impair lung mitochondrial function
Freyre‐Fonseca, V., Delgado‐Buenrostro, N. L., Gutiérrez-Cirlos, E. B., Calderón-Torres, C. M., Cabellos-Avelar, T., Sánchez-Pérez, Y., Pinzón, E., Torres, I., Molina‐Jijón, E., & Zazueta, C. (2011) · Toxicology Letters · doi:10.1016/j.toxlet.2011.01.025 · Cited by 123
Wu, H., Wang, Y., Ying, M., Jin, C., Li, J., & Hu, X. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00595-3 · Cited by 122
Jeong, S. M., Hwang, S., & Seong, R. H. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.02.023 · Cited by 112
Sirois, I., Aguilar-Mahecha, A., Lafleur, J., Fowler, E., Vu, V., Scriver, M., Buchanan, M., Chabot, C., Ramanathan, A., Balachandran, B., et al. (2019) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-19-0264 · Cited by 110
Shiau, J., Chuang, Y.-T., Cheng, Y., Tang, J., Hou, M., Yen, C., & Chang, H. (2022) · Antioxidants · doi:10.3390/antiox11050911 · Cited by 99
Lanning, N. J., Looyenga, B. D., Kauffman, A. L., Niemi, N. M., Sudderth, J., DeBerardinis, R. J., & MacKeigan, J. P. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.03.065 · Cited by 94
Yamada, K. J., Heim, C. E., Xi, X., Attri, K. S., Wang, D., Zhang, W., Singh, P. K., Bronich, T. K., & Kielian, T. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1008354 · Cited by 95
Krebs cycle: activators, inhibitors and their roles in the modulation of carcinogenesis
Gasmi, A., Peana, M., Arshad, M., Butnariu, M., Menzel, A., & Bjørklund, G. (2021) · Archives of Toxicology · doi:10.1007/s00204-021-02974-9 · Cited by 88
Valcarcel‐Ares, M. N., Riveiro-Naveira, R. R., Vaamonde‐García, C., Loureiro, J., Hermida-Carballo, L., Blanco, F. J., & López-Armada, M. J. (2014) · Rheumatology · doi:10.1093/rheumatology/keu016 · Cited by 86
Ruas, J. S., Siqueira-Santos, E. S., Amigo, I., Rodrigues-Silva, E., Kowaltowski, A. J., & Castilho, R. F. (2016) · PLOS ONE · doi:10.1371/journal.pone.0150967 · Cited by 78
Izadifar, Z., Charrez, B., Almeida, M., Robben, S., Pilobello, K. T., van der Graaf-Mas, J., Benz, M., Marquez, S. L., Ferrante, T. C., Shcherbina, K., et al. (2024) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2024.116683 · Cited by 77
Gao, C., Shen, Y., Jin, F., Miao, Y., & Qiu, X. (2016) · PLoS ONE · doi:10.1371/journal.pone.0154576 · Cited by 73
Effects of sorafenib on energy metabolism in breast cancer cells: role of AMPK–mTORC1 signaling
Fumarola, C., Caffarra, C., Monica, S. L., Galetti, M., Alfieri, R. R., Cavazzoni, A., Galvani, E., Generali, D., Petronini, P. G., & Bonelli, M. A. (2013) · Breast Cancer Research and Treatment · doi:10.1007/s10549-013-2668-x · Cited by 70
Urra, F. A., Muñoz, F., Córdova-Delgado, M., Ramírez, M. P., Peña-Ahumada, B., Rios, M., Cruz, P., Ahumada-Castro, U., Bustos, G., Silva-Pavez, E., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-31367-9 · Cited by 69
Computational Repositioning and Preclinical Validation of Pentamidine for Renal Cell Cancer
Zerbini, L. F., Bhasin, M., de Vasconcellos, J. F., Paccez, J. D., Gu, X., Kung, A. L., & Libermann, T. A. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0750 · Cited by 66
AMPK and GCN2–ATF4 signal the repression of mitochondria in colon cancer cells
Martínez‐Reyes, I., Sánchez‐Aragó, M., & Cuezva, J. M. (2012) · Biochemical Journal · doi:10.1042/bj20111829 · Cited by 63
Willers, I. M., & Cuezva, J. M. (2010) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2010.10.016 · Cited by 65
Enslin, L. E., Purkait, K., Pozza, M. D., Saubaméa, B., Mesdom, P., Visser, H. G., Gasser, G., & Schutte‐Smith, M. (2023) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.3c00730 · Cited by 61
The Hypoxia-inducible Factor Renders Cancer Cells More Sensitive to Vitamin C-induced Toxicity
Tian, W., Wang, Y., Xu, Y., Guo, X., Wang, B., Sun, L., Liu, L., Cui, F., Zhuang, Q., Bao, X., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.538157 · Cited by 59
Yu, X., Zhang, L., Yang, X., Huang, H., Huang, Z., Shi, L., Zhang, H., & Du, G. (2012) · Molecules · doi:10.3390/molecules170911216 · Cited by 59
Marignac, V. L. M., Smith, S. E., Toban, N., Bazile, M., & Aloyz, R. S. (2013) · Oncotarget · doi:10.18632/oncotarget.1508 · Cited by 54
He, F., Laranjeira, A. B. A., Kong, T., Lin, S., Ashworth, K. J., Liu, A., Lasky, N. M., Fisher, D. A. C., Cox, M. J., Fulbright, M. C., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci172256 · Cited by 49
Xing, Z., Wang, S., & Tran, E. J. (2017) · RNA · doi:10.1261/rna.060335.116 · Cited by 47
José, C., Melser, S., Bénard, G., & Rossignol, R. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4357 · Cited by 51
Ratajczak, K., Łukasiak, A., Grel, H., Dworakowska, B., Jakieła, S., & Stobiecka, M. (2019) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-019-02061-0 · Cited by 46
Kosaisawe, N., Sparta, B., Pargett, M., Teragawa, C., & Albeck, J. G. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.01.014 · Cited by 52
Distelmaier, F., Valsecchi, F., Liemburg-Apers, D. C., Lebiedzińska, M., Rodenburg, R. J., Heil, S. G., Keijer, J., Fransen, J. A. M., Imamura, H., Danhauser, K., et al. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.12.012 · Cited by 46
Inactivation of Malic Enzyme 1 in Endothelial Cells Alleviates Pulmonary Hypertension
Luo, Y. L., Qi, X., Zhang, Z., Zhang, J., Li, B., Shu, T., Li, X., Hu, H., Li, J., Tang, Q., et al. (2024) · Circulation · doi:10.1161/circulationaha.123.067579 · Cited by 44
Kikuchi, R., Iwai, Y., Tsuji, T., Watanabe, Y., Koyama, N., Yamaguchi, K., Nakamura, H., & Aoshiba, K. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.01.014 · Cited by 44
Regulation of the cell cycle via mitochondrial gene expression and energy metabolism in HeLa cells
Xiong, W., Jiao, Y., Huang, W., Ma, M., Yu, M., Cui, Q., & Tan, D. (2012) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gms006 · Cited by 44
mTOR Inhibitor Everolimus in Regulatory T Cell Expansion for Clinical Application in Transplantation
Gedaly, R., Stefano, F. D., Turcios, L. M., Hill, M., Hidalgo, G. E., Mitov, M. I., Alstott, M. C., Butterfield, D. A., Mitchel, H., Hart, J., et al. (2018) · Transplantation · doi:10.1097/tp.0000000000002495 · Cited by 41
Yu, X. M., Fang, B., Liu, Y., Yan, S., Cao, D., Mei, H., Wang, Q., Hu, Y., & Guo, T. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117971 · Cited by 40
Fischer, A., Zhang, P., Ouyang, Y., Sohn, Y. S., Karmi, O., Nechushtai, R., Pikarsky, E., & Willner, I. (2022) · Small · doi:10.1002/smll.202204108 · Cited by 40
Grande, S., Palma, A., Ricci‐Vitiani, L., Luciani, A. M., Buccarelli, M., Biffoni, M., Molinari, A., Calcabrini, A., D’Amore, E., Guidoni, L., et al. (2018) · Stem Cells International · doi:10.1155/2018/3292704 · Cited by 37
Ma, S., Yeom, J., & Lim, Y. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113672 · Cited by 41
Kennedy, C. R., Tilkens, S. B., Guan, H., Garner, J. A., Or, P. M. Y., & Chan, A. M.-L. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.03.020 · Cited by 38
David, J. M., Owens, T. A., Barwe, S. P., & Rajasekaran, A. K. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0445 · Cited by 36
Ruas, J. S., Siqueira‐Santos, E. S., Rodrigues-Silva, E., & Castilho, R. F. (2018) · Scientific Reports · doi:10.1038/s41598-018-35679-8 · Cited by 36
The Many Facets of Tumor Heterogeneity: Is Metabolism Lagging Behind?
Loponte, S., Lovisa, S., Deem, A. K., Carugo, A., & Viale, A. (2019) · Cancers · doi:10.3390/cancers11101574 · Cited by 36
Integration of Mitochondrial Targeting for Molecular Cancer Therapeutics
Marchetti, P., Guerreschi, P., Mortier, L., & Kluza, J. (2015) · International Journal of Cell Biology · doi:10.1155/2015/283145 · Cited by 39
Liu, H., He, Z., Germič, N., Ademi, H., Frangež, Ž., Felser, A., Peng, S., Riether, C., Djonov, V., Nuoffer, J., et al. (2019) · Cell Death and Differentiation · doi:10.1038/s41418-019-0476-5 · Cited by 30
Gammon, S. T., Pisaneschi, F., Bandi, M. L., Smith, M. G., Sun, Y., Rao, Y., Müller, F. L., Wong, F. C., de Groot, J., Ackroyd, J. J., et al. (2019) · Cells · doi:10.3390/cells8121487 · Cited by 34
Huang, C., Hsu, L., Chen, C.-Y., Chang, G., Chang, H.-W., Hung, Y., Liu, K., & Kao, S. (2020) · Cancers · doi:10.3390/cancers12010181 · Cited by 31
Xue, W., Li, X., Li, W., Wang, Y., Jiang, C., Zhou, L., Gao, J., Yu, Y., Shen, Y., & Xu, Q. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00856-1 · Cited by 33
Meira, W., Heinrich, T. A., Cadena, S. M. S. C., & Martinez, G. R. (2016) · Experimental Cell Research · doi:10.1016/j.yexcr.2016.11.006 · Cited by 29
Advances in metformin‑based metabolic therapy for non‑small cell lung cancer (Review)
Chen, N., Zhou, Y.-S., Wang, L.-C., & Huang, J. (2022) · Oncology Reports · doi:10.3892/or.2022.8266 · Cited by 29
Maeda, Y., Kikuchi, R., Kawagoe, J., Tsuji, T., Koyama, N., Yamaguchi, K., Nakamura, H., & Aoshiba, K. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101093 · Cited by 27
Tau, S. S., Chamberlin, M. D., Yang, H., Marotti, J. D., Muskus, P. C., Roberts, A. M., Carmichael, M. M., Cressey, L. E., Dragnev, C. P. C., Demidenko, E., et al. (2025) · Cancer Research · doi:10.1158/0008-5472.can-24-1204 · Cited by 30
Gnocchi, D., Kurzyk, A., Mintrone, A., Lentini, G., Sabbà, C., & Mazzocca, A. (2022) · Biochimie · doi:10.1016/j.biochi.2022.07.016 · Cited by 25
Basu, S., Broxmeyer, H. E., & Hangoc, G. (2013) · Stem Cells and Development · doi:10.1089/scd.2012.0466 · Cited by 25
Yu, Y., Chen, J., Liu, S., & Cheng, D. (2021) · Journal of Materials Chemistry B · doi:10.1039/d1tb01143j · Cited by 23
Serrill, J., Tan, M. H., Fotso, S., Sikorska, J., Kasanah, N., Hau, A. M., McPhail, K. L., Santosa, D. A., Zabriskie, T. M., Mahmud, T., et al. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.11.015 · Cited by 24
Córdova‐Delgado, M., Fuentes-Retamal, S., Palominos, C., López-Torres, C., Guzmán‐Rivera, D., Ramírez‐Rodríguez, O., Araya‐Maturana, R., & Urra, F. A. (2021) · Antioxidants · doi:10.3390/antiox10101618 · Cited by 22
Mercurio, L., Cecchetti, S., Ricci, A. L., Pacella, A., Cigliana, G., Bozzuto, G., Podo, F., Iorio, E., & Carpinelli, G. (2017) · PLoS ONE · doi:10.1371/journal.pone.0176108 · Cited by 22
Amino Acid and Glucose Fermentation Maintain ATP Content in Mouse and Human Malignant Glioma Cells
Lee, D. C., Ta, N. L., Mukherjee, P., Duraj, T., Domin, M. A., Greenwood, B. P., Karmacharya, S., Narain, N. R., Kiebish, M. A., Chinopoulos, C., et al. (2024) · ASN NEURO · doi:10.1080/17590914.2024.2422268 · Cited by 21
Enogieru, A. B., Haylett, W. L., Miller, H. C., van der Westhuizen, F. H., Hiss, D. C., & Ekpo, O. E. (2019) · Neurotoxicity Research · doi:10.1007/s12640-019-00048-4 · Cited by 21
Ma, D., Hernandez, G. A., Lefebvre, A. E. Y. T., Alshetaiwi, H. S., Blake, K., Davé, K., Rauf, M., Williams, J., Davis, R. T., Evans, K. T., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-02596-y · Cited by 19
Vrieling, F., van der Zande, H. J. P., Naus, B., Smeehuijzen, L., van Heck, J. I. P., Ignacio, B. J., Bonger, K. M., den Bossche, J. V., Kersten, S., & Stienstra, R. (2024) · Cell Reports Methods · doi:10.1016/j.crmeth.2024.100883 · Cited by 21
Gao, C., Dai, Y., Spezza, P. A., Boasiako, P. A., Tang, A., Rasquinha, G., Zhong, H., Shao, B., Liu, Y., Shi, P. A., et al. (2025) · Journal of Clinical Investigation · doi:10.1172/jci189801 · Cited by 21
The Suitability of Glioblastoma Cell Lines as Models for Primary Glioblastoma Cell Metabolism
Arthurs, A. L., Keating, D. J., Stringer, B. W., & Conn, S. J. (2020) · Cancers · doi:10.3390/cancers12123722 · Cited by 20
Morrison, B. L., Mullendore, M. E., Stockwin, L. H., Borgel, S. D., Hollingshead, M. G., & Newton, D. L. (2013) · Cancer Medicine · doi:10.1002/cam4.107 · Cited by 23
Takami, G., Ota, M., Nakashima, A., Kaneko, Y. S., Mori, K., Nagatsu, T., & Ota, A. (2010) · Journal of Neural Transmission · doi:10.1007/s00702-010-0457-9 · Cited by 18
Schneegans, S., Löptien, J., Mojzisch, A., Loreth, D., Kretz, O., Raschdorf, C., Hanssen, A., Gocke, A., Siebels, B., Gunasekaran, K., et al. (2024) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-024-03020-z · Cited by 19
Monitoring the Effects of Pharmacological Reagents on Mitochondrial Morphology
Fu, D., & Lippincott‐Schwartz, J. (2018) · Current Protocols in Cell Biology · doi:10.1002/cpcb.45 · Cited by 17
Proteomic analysis of a mosquito host cell response to persistent Wolbachia infection
Baldridge, G. D., Higgins, L., Witthuhn, B. A., Markowski, T. W., Baldridge, A. S., Armién, A. G., & Fallon, A. M. (2017) · Research in Microbiology · doi:10.1016/j.resmic.2017.04.005 · Cited by 16
Metabolic regulation of the CCN family genes by glycolysis in chondrocytes
Akashi, S., Nishida, T., El-Seoudi, A., Takigawa, M., Iida, S., & Kubota, S. (2017) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-017-0420-8 · Cited by 16
Basu, S. (2013) · Stem Cell Research · doi:10.1016/j.scr.2013.10.006 · Cited by 14
Grimm, F., Asuaje, A., Jain, A., dos Santos, M. S., Kleinjung, J., Nunes, P. M., Gehrig, S. M., Fets, L., Darici, S., MacRae, J. I., et al. (2024) · The EMBO Journal · doi:10.1038/s44318-024-00065-w · Cited by 15
Mitochondrial dysfunction and epithelial to mesenchymal transition in head neck cancer cell lines
Greier, M. C., Runge, A., Dudás, J., Pider, V., Skvortsova, I., Savic, D., & Riechelmann, H. (2022) · Scientific Reports · doi:10.1038/s41598-022-16829-5 · Cited by 12
A novel acyclic oligomycin A derivative formed via retro-aldol rearrangement of oligomycin A
Lysenkova, L. N., Turchin, K. F., Korolev, A. M., Bykov, E. E., Даниленко, В. Н., Bekker, O. B., Trenin, A. S., Elizarov, S. M., Dezhenkova, L. G., Shtil, A. A., et al. (2012) · The Journal of Antibiotics · doi:10.1038/ja.2012.38 · Cited by 12
Rodrigues-Silva, E., Siqueira‐Santos, E. S., Ruas, J. S., Ignarro, R. S., Figueira, T. R., Rogério, F., & Castilho, R. F. (2017) · Journal of Neuro-Oncology · doi:10.1007/s11060-017-2482-0 · Cited by 12
He, L., He, Z., April-Monn, S., Trefny, M. P., Rougier, J., Salemi, S., Olariu, R., Widmer, H. R., & Simon, H. (2018) · Cell Death and Differentiation · doi:10.1038/s41418-018-0182-8 · Cited by 12
Palma, A., Grande, S., Ricci‐Vitiani, L., Luciani, A. M., Buccarelli, M., Biffoni, M., Dini, V., Cirrone, G. A. P., Ciocca, M., Guidoni, L., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21145167 · Cited by 12
Mirveis, Z., Patil, N., & Byrne, H. J. (2024) · FEBS Open Bio · doi:10.1002/2211-5463.13841 · Cited by 9
Shen, C., Yue, X., Dai, L., Wang, J., Li, J., Fang, Q., Zhi, Y., Shi, C., & Li, W. (2022) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-022-04385-4 · Cited by 10
Kinetic modelling of the cellular metabolic responses underpinning in vitro glycolysis assays
Patil, N., Mirveis, Z., & Byrne, H. J. (2024) · FEBS Open Bio · doi:10.1002/2211-5463.13765 · Cited by 10
Rizi, B. S., Braasch, K., Salimi, E., Butler, M., Bridges, G. E., & Thomson, D. J. (2014) · Biomicrofluidics · doi:10.1063/1.4903221 · Cited by 9
Su, S., Su, S.-J., Huang, L., & Chiang, Y.-C. (2023) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2023.01.025 · Cited by 9
Scherbakov, A. M., Sorokin, D. V., Omelchuk, O. A., Shchekotikhin, A. E., & Ma, K. (2021) · Biochimie · doi:10.1016/j.biochi.2021.04.003 · Cited by 9
Potentiation of Anti-Cancer Treatment by Modulators of Energy Metabolism
Shoshan, M. C. (2013) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201011314030007 · Cited by 9
ATP Restoration by ATP-Deprived Cultured Primary Astrocytes
Karger, G., Willker, J. E., Harders, A. R., Watermann, P., & Dringen, R. (2024) · Neurochemical Research · doi:10.1007/s11064-024-04276-9 · Cited by 8
Das, S., Zea, M. P., Russon, M. P., Xing, Z., Torregrosa‐Allen, S. E., Cervantes, H. E., Harper, H. A., Elzey, B. D., & Tran, E. J. (2025) · iScience · doi:10.1016/j.isci.2025.112219 · Cited by 10
Cardiosphere-Derived Cells Demonstrate Metabolic Flexibility That Is Influenced by Adhesion Status
Afzal, J. M., Chan, A. T., Karakaş, M. F., Woldemichael, K., Vakrou, S., Guan, Y., Rathmell, J. C., Wahl, R. L., Pomper, M. G., Foster, D. B., et al. (2017) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2017.03.016 · Cited by 8
Conserved role of ATP synthase in mammalian cilia
Lin, W., Qiao, C., Hu, J., Wei, Q., & Xu, T. (2021) · Experimental Cell Research · doi:10.1016/j.yexcr.2021.112520 · Cited by 8
Zhou, Q., Wang, W., He, X., Zhu, X., Shen, Y., Yu, Z., Wang, X., Qi, X., Zhang, X., Fan, M., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090336 · Cited by 7
Metadata
- Authors
- Hao, W., Chang, C.-P. B., Tsao, C.-C., & Xu, J.
- Affiliations
- Wyeth (US)
- Corresponding author
- Hao, Wenshan
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2010-04
- Volume
- 285
- Issue
- 17
- Pages
- 12647-12654
- ISSN
- 0021-9258 (ISSN-L)
- PMC
- PMC2857128
- OpenAlex
- W2009114717
- Cited by
- 138
- References
- 24
- Citations by year
- 2026: 6 · 2025: 11 · 2024: 12 · 2023: 7 · 2022: 8 · 2021: 11 · 2020: 10 · 2019: 13 · 2018: 8 · 2017: 8 · 2016: 6 · 2015: 3 · 2014: 12 · 2013: 10 · 2012: 8
- FWCI
- 2.31
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer and biochemical research
- Keywords
- oligomycin, cancer cells, oxidative phosphorylation inhibition, AMPK, acetyl-CoA carboxylase, glycolysis, ATP homeostasis, LKB1, hypoxia, energy stress, cell growth inhibition
- MeSH terms
- AMP-Activated Protein Kinase Kinases, Acetyl-CoA Carboxylase, Adenosine Triphosphate, Dose-Response Relationship, Drug, Enzyme Activation, Glycolysis, Humans, Mitochondria, Neoplasm Proteins, Neoplasms, Oligomycins, Oxidative Phosphorylation, Phosphorylation, Stress, Physiological, Time Factors, Uncoupling Agents, Cell Hypoxia, Protein Serine-Threonine Kinases, Cell Line, Tumor, AMP-Activated Protein Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
